Inhibition of matrix metalloproteinase 9 expression by a ribozyme blocks metastasis in a rat sarcoma model system

Cancer Research

Volumn 56, Issue 22, 1996, Pages 5279-5284

  Hua, Jin ^a   Muschel, Ruth J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE; GELATINASE B; RIBOZYME;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; EMBRYO CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GEL ELECTROPHORESIS; METASTASIS; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN TARGETING; RAT; RNA SEQUENCE; SARCOMA;

ANIMALS; COLLAGENASES; DOWN-REGULATION; LUNG NEOPLASMS; MATRIX METALLOPROTEINASE 9; MICE; RATS; RNA, CATALYTIC; RNA, MESSENGER; SARCOMA, EXPERIMENTAL; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0029824947     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Stetler-Stevenson, W. G., Aznavoorian, S., and Liotta, L. A. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu. Rev. Cell Biol., 9: 541-573, 1993.
2. Birkedal-Hansen, H. Proteolytic remodeling of extracellular matrix. Curr Opin. Cell Biol., 7: 728-735, 1995.
3. Powell, W. C., and Matrisian, L. M. Complex roles of matrix metalloproteinases in tumor progression. Curr. Topics Microbiol Immunol., 213, 1-21, 1996.
4. Pel, D., and Weiss, S. J. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature (Lond), 375: 244-247, 1995.
5. Wilhelm, S., Collier, I., Marmer, B., Eisen, A., Grant, G., and Goldberg, G. SV-40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J. Biol Chem., 264: 17213-17221, 1989.
6. Goldberg, G. I., Strongin, A., Collier, I. E., Genrich, L. T., and Marmer, B. L. Interaction of 92-kDa type IV collagenase with the tissue inhibitor of metalloproteinases prevents dimerization, complex formation with interstitial collagenase, and activation of the proenzyme with stromelysin J. Biol. Chem., 267: 4583-4591, 1992.
7. Grant, G. A., Goldberg, G. I., Wilhelm, S. M., He, C., and Eisen, A. Z. Activation of extracellular matrix metalloproteases by proteases and organomercurials Matrix, I (Suppl.): 217-223, 1992.
8. Okada, Y., Gonoji, Y., Naka, K., Tomita, K., Nakanishi, I., Iwata, K., Yamashita, K., and Hayakawa, T. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J. Biol. Chem., 267: 21712-21719, 1992.
9. Fridman, R., Toth, M., Pena, D., and Mobashery, S. Activation of progelatinase B (MMP-9) by gelatinase A (MMP-2). Cancer Res., 55: 2548-2555, 1995.
10. Ogata, Y., Itoh, Y., and Nagase, H. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J. Biol. Chem., 270: 18506-18511, 1995.
11. Shapiro, S. D., Fliszar, C. J., Broekelmann, T. J., Mecham, R. P., Senior, R. M., and Welgus, H. G. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J. Biol. Chem., 270: 6351-6356, 1995.
12. Desrivieres, S., Lu, H., Peyri, N., Soria, C., Legrand, Y., and Menashi, S. Activation of the 92 kDa type IV collagenase by tissue kallikrem J. Cell Physiol., 157: 587-593, 1993.
13. Ochieng, J., Fridman, R., Nangiamakker, P., Kleiner, D., Liotta, L., Stetler-Stevenson, W., and Raz, A. Galectin-3 is a novel substrate for human matrix metalloproteinase-2 and metalloproteinase-9. Biochemistry, 33: 14109-14114, 1994.
14. Gearing, A. J., Beckett, P., Christodoulou, M., Churchill, M., Clements, J. M., Crimmin, M., Davidson, A. H., Drummond, A. H., Galloway, W. A., Gilbert, R., Gordon, J. L., Leber, T. M., Mangan, M., Miller, K., Nayee, P., Owen, K., Patel, S., Thomas, W., Wells, G., Wood, L. M., and Woolley, K. Matrix metalloproteinases and processing of pro-TNF-α. J. Leukocyte Biol., 57: 774-777, 1995.
15. Netzel-Arnett, S., Sang, Q. X. Moore, W. G. Navre, M., Birkedal-Hansen, H., and Van Wart, H. E. Comparative sequence specificities of human 72- and 92-kDa gelatinases (type IV collagenases) and PUMP (matrilysin). Biochemistry, 32: 6427-6432, 1993.
16. Himelstein, B. P., Canete-Soler, R., Bernhard, E. J., Dilks, D. W., and Muschel, R. J. Metalloproteinases in tumor progression - the contribution of MMP-9 Invasion & Metastasis, 14: 246-258, 1994.
17. Ballin, M., Gomez, D., Sinha, C., and Thorgeirsson, U. Ras oncogene mediated induction of a 92 kDa metalloproteinase: strong correlation with the malignant phenotype. Biochem. Biophys Res Commun., 154: 832-838, 1988.
18. Watanabe, H., Nakanishi, I., Yamashita, K., Hayakawa, T., and Okada, Y. Matrix metalloproteinase-9 (92 kDa gelatinase/type IV collagenase) from U937 monoblastoid cells: correlation with cellular invasion. J. Cell Sci. 104: 991-999, 1993.
19. MacDougall, J. R., Bani, M. R., Lin, Y., Rak, J., and Kerbel, R. S. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: suppression by somatic cell hybridization with early stage melanoma cells. Cancer Res., 55: 4174-4181, 1995.
20. Sehgal, I., Baley, P. A., and Thompson, T. C. Transforming growth factor β 1 stimulates contrasting responses in metastatic versus primary mouse prostate cancer derived cell lines in vitro. Cancer Res., 56: 3359-3365, 1996.
21. Bernhard, E., Hagner, B., Lubensky, I., Wong, C., and Muschel, R. The effect of E1A transfection on MMP-9 expression and metastatic potential Int. J. Cancer, 60: 718-724, 1995.
22. Bernhard, E., Muschel, R., and Hughes, E. 92-kDa gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res., 50: 3872-3877, 1990.
23. Pozzatti, R., McCormick, M., Thompson, M., and Khoury, G. The Ela of adenovirus 2 reduces the metastatic potential of ras-transformed rat embryo cells. Mol. Cell. Biol., 8: 2984-2988, 1988.
24. Sreenath, T., Matrisian, L., Stetler-Stevenson, W., Gattoni-Celli, S., and Pozzatti, R. Expression of matrix melalloproteinase genes in transformed rat cell lines of high and low metastatic potential Cancer Res., 52: 4942-4947, 1992.
25. Bernhard, E., Gruber, S., and Muschel, R. Direct evidence linking MMP-9 (92 kDa gelatinase/collagenase) expression to the metastatic phenotype in transformed rat embryo cells Proc. Natl Acad Sci. USA., 91, 4293-4297, 1994.
26. Sarver, N., Cantin, E., Chang, P., Zaia, J., Ladne, P., Stephens, D., and Rossi, J. Ribozymes as potential anti-HIV-1 therapeutic agents. Science (Washington DC), 247: 1222-1225, 1990.
27. Scott, W. G., Finch, J. T., and Klug, A. The crystal structure of an all-RNA hammerhead ribozyme: a proposed mechanism for RNA catalytic cleavage. Cell, 81: 991-1002, 1995.
28. Sigurdsson, S. T., and Eckstein, F. Structure-function relationships of hammerhead ribozymes: from understanding to applications Trends Biotechnol, 13: 286-289, 1995.
29. Castanotto, D., Rossi, J. J., and Sarver, N. Antisense catalytic RNAs as therapeutic agents. Adv Pharmacol, 25, 289-317, 1994.
30. Kashani-Sabet, M., Funato, T., Florenes, V. A., Fodstad, O., and Scanlon, K. J. Suppression of the neoplastic phenotype in vivo by an anti-ras ribozyme. Cancer Res., 54: 900-902, 1994.
31. Cech, T. R., Herschlag, D., Piccinlli, J. A., and Pyle, A. M RNA catalysis by a group I ribozyme Developing a model for transition state stabilization. J. Biol. Chem., 267: 17479-17482, 1992.
32. Muschel, R., Williams, J., Lowy, D., and Liotta, L. Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. Am J. Pathol., 121: 1-8, 1985.
33. Chomczynski, P., and Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem., 162: 156-159, 1987.
34. Meyuhas, O., and Perry, R. P. Construction and identification of cDNA clones for mouse ribosomal proteins: applications for the study of r-protein gene expression. Gene (Amst), 10: 113-129, 1980.
35. Maity, A., McKenna, W. G., and Muschel, R. J. Posttranscriptional regulation of cyclin B1 mRNA through the cell cycle and after irradiation. EMBO J., 14: 603-609, 1994.
36. Kawamata, H., Kameyama, S., Kawai, K., Tanaka, Y., Nan, L., Barch, D. H., Stetler-Stevenson, W. G., and Oyasu, R. Marked acceleration of the metastatic phenotype of a rat bladder carcinoma cell line by the expression of human gelatinase A. Int. J. Cancer, 63: 568-575, 1995.
37. r 72,000 matrix metalloproteinase at cell surface invadopodia Cancer Res., 53: 3159-3164, 1993.
38. Sato, H., Takino, T., Okada, Y., Cao, J., Shinagawa, A., Yamamoto, E., and Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumour cells Nature (Lond), 370: 61-65, 1994.
39. Brooks, P. C., Stromblad, S., Sanders, L. C., von Schalscha, T. L., Aimes, R. T., Stetler-Stevenson, W. G., Quigley, J. P., and Cheresh, D. A. Localization of matrix metalloproteinase MMP-2 to the surface of invasive cels by interaction with integrin aVb3. Cell, 85: 683-694, 1996.
40. Witty, J. P., McDonnell, S., Newell, K. J., Cannon, P., Navre, M., Tressler, R. J., and Matristan, L. M. Modulation of matrilysin levels in colon carcinoma cell lines affects tumorigenicity in vivo. Cancer Res., 54: 4805-4812, 1994.
41. Powell, W. C., Knox, J. D., Navre, M., Grogan, T. M., Kittelson, J., Nagle, R. B., and Bowden, G. T. Expression of the metalloproteinase matrilysin in DU-145 cells increases their invasive potential in severe combined immunodeficient mice. Cancer Res., 53: 417-422, 1993.
42. Canete-Soler, R., Litzky, L., Lubensky, I., and Muschel, R. J. Localization of the 92 Kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am J. Pathol., 144: 518-527, 1994.
43. Karelina, T. V., Hruza, G. J., Goldberg, G. I., and Eisen, A. Z. Localization of 92 kDa type IV collagenase in human skin tumors: comparison with normal human fetal and adult skin. J. Invest. Dermatol., 100: 159-165, 1993.
44. Juarez, J., Clayman, G., Nakajima, M., Tanabe, K. K., Saya, H., Nicolson, G. L., and Boyd, D. Role and regulation of expression of 92 kDa type-IV collagenase (MMP-9) in 2 invasive squamous-cell-carcinoma cell lines of the oral cavity. Int. J. Cancer., 55: 10-18, 1993.
45. Nakagawa, H., and Yagihashi, S. Expression of type IV collagen and its degrading enzymes in squamous cell carcinoma of lung. Jpn. J. Cancer Res., 85: 934-938, 1994.
46. Miyajima, Y., Nakano, R., and Morimatsu, M. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization Ann. Otol. Rhinol. Laryngol., 104: 678-684, 1995.
47. Rao, J. S., Yamamoto, M., Mohaman, S., Gokaslan, Z. L., Fuller, G. N., Stetler-Stevenson, W. G., Rao, V. H., Liotta, L. A., Nicolson, G. L., and Sawaya, R. E. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas. Clin. & Exp. Metastasis, 14: 12-18, 1996.
48. Nakano, A., Tani, E., Miyazaki, K., Yamamoto, Y., and Furuyama, J. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in human gliomas. J. Neurosurg., 83: 298-307, 1995.
49. Kossakowska, A. E., Urbanski, S. J., Watson, A., Hayden, L. J., and Edwards, D. R. Patterns of expression of metalloproteinases and their inhibitors in human malignant lymphomas. Oncol. Res., 5: 19-28, 1993.
50. Gress, T. M., Muller-Pillasch, F., Lerch, M. M., Friess, H., Buchler, M., and Adler, G. Expression and in situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer. Int J. Cancer, 62: 407-413, 1995.
51. Duffy, M. J., Blaser, J., Duggan, C., McDermott, E., O'Higgins, N., Fennelly, J. J., and Tschesche, H. Assay of matrix metalloproteases types 8 and 9 by ELISA in human breast cancer Br. J. Cancer, 71: 1025-1028, 1995.
52. Visscher, D. W., Hoyhtya, M., Ottosen, S. K., Liang, C. M., Sarkar, F. H., Crissman, J. D., and Fridman, R. Enhanced expression of tissue inhibitor of metalloproteinase-2 (TIMP-2) in the stroma of breast carcinomas correlates with tumor recurrence. Int. J. Cancer, 59: 339-344, 1994.
53. Davies, B., Miles, D. W., Happerfield, L. C., Naylor, M. S., Bobrow, L. G., Rubens, R. D., and Balkwill, F. R. Activity of type IV collagenases in benign and malignant breast disease Br. J. Cancer, 67: 1126-1131, 1993.
54. Canete Soler, R., Gui, Y. H., Linask, K. K., and Muschel, R. J. MMP-9 (gelatinase B) mRNA is expressed during mouse neurogenesis and may be associated with vascularization Dev. Brain Res., 88: 37-52, 1995.
55. Canete-Soler, R., Gui, Y. H., Linask, K. K., and Muschel, R. J. Developmental expression of MMP-9 (gelatinase B) mRNA in mouse embryos. Dev. Dyn., 204: 30-40, 1995.
56. Reponen, P., Sahlberg, C., Munaut, C., Thesleff, I., and Tryggvason, K. High expression of 92 kDa type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development J. Cell. Biol., 124: 1091-1102, 1994.
57. Reponen, P., Leivo, I., Sahlberg, C., Apte, S. S., Olsen, B. R., Thesleff, I., and Tryggvason, K. 92 kDa type IV collagenase and TIMP-3, but not 72 kDa type IV collagenase or TIMP-1 or TIMP-2, are highly expressed during mouse embryo implantation. Dev Dyn., 202, 388-396, 1995.